OPTIMER PHARMACEUTICALS INC (OPTR) financial statements (2020 and earlier)

Company profile

Business Address 101 HUDSON STREET
JERSEY CITY, NJ 07302
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments124
Cash and cash equivalents119
Short-term investments5
Receivables10
Inventory, net of allowances, customer advances and progress billings15
Inventory15
Prepaid expense and other current assets3
Total current assets:152
Noncurrent Assets
Property, plant and equipment4
Long-term investments and receivables1
Long-term investments1
Prepaid expense and other noncurrent assets1
Deferred tax assets, net1
Total noncurrent assets:7
TOTAL ASSETS:159
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34
Accounts payable7
Accrued liabilities19
Employee-related liabilities7
Deferred revenue and credits0
Other undisclosed current liabilities(7)
Total current liabilities:27
Noncurrent Liabilities
Liabilities, other than long-term debt2
Deferred revenue and credits1
Accrued income taxes1
Total noncurrent liabilities:2
Total liabilities:29
Stockholders' equity
Stockholders' equity attributable to parent131
Common stock0
Additional paid in capital382
Accumulated other comprehensive income0
Accumulated deficit(252)
Total stockholders' equity:131
TOTAL LIABILITIES AND EQUITY:159

Income statement (P&L) ($ in millions)

12/31/2012
Revenues102
Revenue, net62
Cost of revenue(35)
Cost of goods and services sold(5)
Gross profit:66
Operating expenses(157)
Operating loss:(91)
Nonoperating income0
Investment income, nonoperating32
Other undisclosed income from continuing operations before equity method investments, income taxes54
Loss from continuing operations before equity method investments, income taxes:(37)
Loss from equity method investments(2)
Loss from continuing operations before income taxes:(38)
Income tax benefit0
Loss before gain (loss) on sale of properties:(38)
Other undisclosed net income1
Net loss:(37)
Net income attributable to noncontrolling interest0
Net loss available to common stockholders, diluted:(37)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(37)
Other comprehensive income1
Comprehensive loss:(37)
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)
Other undisclosed comprehensive income, net of tax, attributable to parent0
Comprehensive loss, net of tax, attributable to parent:(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: